Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
Date:8/3/2009

erweight patients with type 2 diabetes. Results from BLOOM-DM will be submitted as a supplement to the lorcaserin NDA filing.
  • Announced a late-breaking poster presentation of positive results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal trials evaluating the safety and efficacy of lorcaserin for weight management, at the 69th Scientific Sessions of the American Diabetes Association. Lorcaserin patients achieved highly significant categorical and absolute weight loss in Year 1, and continued treatment with lorcaserin in Year 2 helped significantly more patients maintain their weight loss as compared to those on placebo. 66.4% of lorcaserin patients who completed one year of treatment according to the trial's protocol lost at least 5% of their weight and the average weight loss in this responder population was 26 pounds. Treatment with lorcaserin also resulted in highly significant improvements as compared to placebo in multiple secondary endpoints associated with cardiovascular risk. Lorcaserin was very well tolerated, did not result in increased risk of depression and was not associated with development of cardiac valvular insufficiency.
  • Ortho-McNeil-Janssen completed a Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of a single ascending dose of APD597 in healthy volunteers. Ortho-McNeil-Janssen has initiated another clinical trial evaluating multiple ascending doses of APD597.
  • Completed a public offering of 12.5 million shares of common stock, resulting in net proceeds to Arena of approximately $49.7 million.
  • Received net proceeds of $95.6 million from a $100.0 million secured loan provided by Deerfield Management. The outstanding principal accrues interest until maturity in June 2013 at a rate of 7.75% per annum. In connection with the loan, Arena issued Deerfield warrants for 28 million
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine news :

    1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
    2. Arena Pharmaceuticals Announces Public Offering of Common Stock
    3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
    4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
    6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
    7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
    9. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
    10. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
    11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/28/2015)... The California-based leading wig brand UniWigs has ... on UniWigs during the Easter Holidays from today until ... on April Fools’ Day. , As the winter fades ... corner. Easter Festival, with religious origins to countries in ... after Christmas. The best wig provider, UniWigs, would like ...
    (Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
    (Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
    (Date:3/28/2015)... 28, 2015 Early surgery may not ... V AC joint injuries, according to new research from ... the American Orthopaedic Society for Sports Medicine’s ( AOSSM ... faster when surgery was not performed. , The final ... surgical treatment and 17 receiving non-surgical therapy. Of the ...
    (Date:3/28/2015)... OR (PRWEB) March 28, 2015 Lately ... the media regarding recent changes and proposals around the ... , current and former collegiate student-athletes across a spectrum ... and reflect on common challenges. The special panel consists ... country in sports ranging from football, track and field, ...
    Breaking Medicine News(10 mins):Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
    ... 14 (HealthDay News) -- Watching this year,s NCAA March Madness ... bet on the games, one expert suggests. Though the ... message boards seems to suggest that predicting the outcome of ... M. Nowlis, a marketing professor at the Olin Business School ...
    ... Department of Energy,s (DOE) Brookhaven National Laboratory, Stony Brook ... "wearable," portable PET scanner they,ve developed for rats. The ... studying brain function and behavior in fully awake, moving ... studies in the April 2011 issue of Nature Methods. ...
    ... , FRIDAY, March 11 (HealthDay News) -- Forget that ... in romantic relationships. Those who are unrealistically idealistic ... than the realists, new research contends. The idealization ... that strikes marriages over time, said study author Dr. ...
    ... invasive breast cancer in the same breast are at ... who do not develop invasive disease, according to a ... of the National Cancer Institute. Retrospective studies ... (lumpectomy) to mastectomy and found that survival rates are ...
    ... News) -- A doctor,s empathy can improve the care of ... being a good doctor, according to a new study. ... and June 2009 by 29 doctors at Thomas Jefferson University ... empathy for patients, while the quality of patient care was ...
    ... UC Irvine,s Dr. Bang H. Hoang and colleagues have ... for their work advancing the understanding of how bone cancer ... was announced at the recent American Academy of Orthopaedic Surgeons ... the most prestigious honors bestowed by the AAOS and the ...
    Cached Medicine News:Health News:Miniature 'wearable' PET scanner ready for use 2Health News:Miniature 'wearable' PET scanner ready for use 3Health News:Miniature 'wearable' PET scanner ready for use 4Health News:Think You Have a Perfect Partner? That's a Good Sign 2Health News:Think You Have a Perfect Partner? That's a Good Sign 3Health News:DCIS patients who get invasive breast cancer have higher mortality 2
    (Date:3/27/2015)... YORK , March 27, 2015 Object ... the blind, visually impaired and elderly. The VelaSense ... these individuals to lead more independent, productive and fulfilling ... Technology which will allow users to identify objects from ... as well as create customized object databases for personal ...
    (Date:3/27/2015)... AUGUSTA, Ga. , March 27, 2015  Holographic ... innovator in the field of holographic medical imaging, is ... of its Kickstarter campaign. Launching on April 20 th ... Voxbox and Voxbox Pro. The 8-inch and 22-inch displays ... at home for the first time. In addition to ...
    (Date:3/27/2015)... , March 27, 2015   Cypher ... today announced new data showing that, compared to ... technology provided highly equivalent interpretations of whether ... and did so in a fraction of the ... way for more comprehensive genetic analysis in non-invasive ...
    Breaking Medicine Technology:VelaSense Object Recognition Technology for the Blind was unveiled at Baruch College's CCVIP 8th Annual Conference 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3
    ... 31, 2011 Polaris Group (Polaris) today announced that ... the company,s Special Protocol Assessment (SPA) for a Phase ... in patients with advanced hepatocellular carcinoma (HCC). The randomized, ... have failed prior systemic chemotherapy. The primary endpoint of ...
    ... 2011 Amarin Corporation plc (Nasdaq: AMRN ... cardiovascular disease, today announced that Executive Chairman and Chief ... EDT on April, 6, 2011 at the 10th Annual ... President, John Thero, will be available at the conference ...
    Cached Medicine Technology:FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma 2FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma 3Amarin to Present at the 10th Annual Needham Healthcare Conference 2
    ... Neuroprene™ soft supports are a ... to proprioceptive taping for common orthopedic ... help provide specific compression and lateral ... receptors (proprioceptors) in the skin and ...
    ... The C.Ti.2 Hockey is a lightweight, ... meet the unique requirements of hockey,players. Tested ... a new, streamlined frame shape that is ... (VMO). Plus, the upper and lower lateral ...
    ... Adjustable Patella Donut is a neoprene ... core and polyester Lycra Fabric that ... full-circumference donut provides for patellar control. ... based allergies or irritations. Click here ...
    The Deluxe Knee Immobilizer provides superb lightweight immobilization following injury or surgery. It is available in a wide array of sizes for excellent comfort and fit....
    Medicine Products: